Clinical Trials on Hereditary Leiomyomatosis and Renal Cell Cancer
Total 10833 results
-
Wenxin XuRecruitingKidney Cancer | Renal Cell Carcinoma | Metastatic Renal Cell CarcinomaUnited States
-
Mabpro, a.s.Not yet recruitingHead and Neck Cancer | Mesothelioma, Malignant | TNBC - Triple-Negative Breast Cancer | Non-small-cell Lung Carcinoma | Clear Cell Renal Cell Carcinoma Metastatic
-
Fudan UniversityRecruitingKidney Cancer | Renal Cell Carcinoma | Renal Clear Cell CarcinomaChina
-
Argos TherapeuticsTerminatedRenal Cell Carcinoma | Metastatic Renal Cell Carcinoma | Advanced Renal Cell CarcinomaIsrael, Spain, United States, Czechia, Canada, Italy, Hungary, United Kingdom
-
Ohio State University Comprehensive Cancer CenterBayer; NovartisCompletedMelanoma | Renal CancerUnited States
-
Biorek S.R.L.RecruitingRenal Cell Carcinoma | Angiomyolipoma | Tumor, Solid | OncocytomaItaly, Spain
-
Stanford UniversityNational Institutes of Health (NIH)Active, not recruitingKidney Cancer | Renal Cell Carcinoma | Metastatic Renal Cell CarcinomaUnited States
-
Ontario Clinical Oncology Group (OCOG)Bristol-Myers SquibbActive, not recruitingMetastatic Renal Cell CarcinomaCanada, Australia
-
Gustave Roussy, Cancer Campus, Grand ParisSuspendedClear Cell Renal Cell Carcinoma | Head and Neck Cancer | Gastric Adenocarcinoma | Pancreatic Ductal Adenocarcinoma | Biliary Tract Cancer | Urothelial Bladder Cancer | Gastro-oesophageal Adenocarcinoma | Platinum-sensitive Urothelial Bladder CancerFrance
-
Krystal Biotech, Inc.RecruitingMetastatic Renal Cell Carcinoma | Metastatic Colorectal Cancer | Lung Cancer Metastatic | Lung Cancer, Non-small Cell | Advanced Cancer | Solid Tumor, Adult | Metastatic Osteosarcoma | Metastatic Sarcoma | Metastatic Hepatocellular Carcinoma | Lung Cancer, Small CellUnited States
-
Bristol-Myers SquibbCompletedKidney Cancer | Renal Cell CarcinomaJapan
-
M.D. Anderson Cancer CenterNovartisTerminated
-
Johns Hopkins UniversityCompletedKidney Cancer | Renal Cell CarcinomaUnited States
-
Jørgen Bjerggaard JensenCompletedRenal Cell Carcinoma | Bladder CancerDenmark
-
SCRI Development Innovations, LLCAstraZeneca; Genentech, Inc.CompletedKidney CancerUnited States
-
Agenus Inc.TerminatedKidney Cancer | Renal Cell CarcinomaUnited States, Canada
-
University of ChicagoNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and UreterUnited States, Canada
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedRenal Cell Carcinoma | Metastatic Melanoma | Non-small Cell Lung Cancer | Metastatic Castration-resistant Prostrate CancerUnited States
-
First Affiliated Hospital, Sun Yat-Sen UniversitySun Yat-sen University; Health Science Center of Xi'an Jiaotong University; Yantai...Not yet recruitingRenal Neoplasms | Targeted Molecular Therapy
-
Queen Mary University of LondonAstraZeneca; Vall d'Hebron Institute of OncologyActive, not recruitingRenal Clear Cell Carcinoma | Renal Papillary Cell CarcinomaUnited Kingdom
-
Ceevra, Inc.CompletedKidney Cancer | Renal Cell CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedKidney Cancer | Renal Cell CarcinomaUnited States
-
Novo Nordisk A/SCompletedRenal Cell Carcinoma | CancerGermany, Netherlands
-
Bristol-Myers SquibbCompletedAdvanced CancerUnited States, Israel, Australia, Austria, Canada, Italy
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Unknown
-
M.D. Anderson Cancer CenterGenentech, Inc.CompletedKidney Cancer | Renal Cell CarcinomaUnited States
-
University Hospital, BordeauxNational Cancer Institute (NCI)Completed
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer Institute; Genentech, Inc.; Brigham and Women's Hospital; Vanderbilt...CompletedKidney Cancer | Renal Cell CarcinomaUnited States
-
M.D. Anderson Cancer CenterEli Lilly and CompanyCompletedKidney Cancer | Renal Cell CarcinomaUnited States
-
M.D. Anderson Cancer CenterNovartis PharmaceuticalsCompletedKidney Cancer | Renal Cell CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterNovartisCompletedKidney Cancer | Renal Cell CarcinomaUnited States
-
Dana-Farber Cancer InstituteGenentech, Inc.Active, not recruitingAdvanced Non-Clear Cell Kidney CancerUnited States
-
University Health Network, TorontoNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and UreterUnited States, Canada
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedRecurrent Renal Cell Carcinoma | Stage IV Skin Melanoma | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | Metastatic Pancreatic Adenocarcinoma | Recurrent Pancreatic Carcinoma | Stage IV Breast Cancer | Recurrent Breast Carcinoma | Recurrent Colorectal Carcinoma | Colorectal... and other conditionsUnited States
-
Centre hospitalier de l'Université de Montréal...Bristol-Myers SquibbActive, not recruitingMelanoma | Small Cell Lung Cancer | Non Small Cell Lung Cancer Metastatic | Brain Metastases, Adult | Clear-Cell Metastatic Renal Cell CarcinomaCanada
-
Interessenverband zur Qualitätssicherung der Arbeit...OnkoDataMed GmbHTerminatedMetastatic Renal Cell Carcinoma | Locally Advanced Renal Cell CarcinomaGermany
-
National Cancer Institute (NCI)TerminatedMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter | Regional Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage III Bladder Cancer | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | Stage... and other conditionsUnited States
-
TC BiopharmTerminatedNon-small Cell Lung Cancer | Renal Cell Cancer | Malignant MelanomaUnited Kingdom
-
Novartis PharmaceuticalsTerminatedOvarian Cancer | Non-small Cell Lung Cancer (NSCLC) | Renal Cell Carcinoma (RCC) | Triple Negative Breast Cancer (TNBC) | Pancreatic Ductal Adenocarcinoma (PDAC) | Metastatic Castration Resistant Prostate Cancer (mCRPC) | Colorectal Cancer Microsatellite Stable (MSS)Canada, Australia, Singapore, United States, Japan, Spain, United Kingdom
-
RenJi HospitalCompletedNeoadjuvant Therapy of Non-metastatic Locally Advanced Renal Cell CarcinomaChina
-
Portage BiotechTarus Therapeutics, Inc.Active, not recruitingNon Small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Renal Cell Cancer | Castrate Resistant Prostate CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteCompletedRenal Cell Carcinoma | Non-Small Cell Lung Cancer | NSCLC | Solid Tumor | Metastatic Cancer | Squamous Cell Carcinoma of the Head and Neck | Urothelial Carcinoma | Squamous Cell Carcinoma | Recurrent CancerUnited States
-
National Cancer Institute (NCI)RecruitingStage IV Renal Cell Cancer AJCC v8 | Sarcomatoid Renal Cell Carcinoma | Stage IV Bladder Cancer AJCC v8 | Stage IV Urethral Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Bladder Adenocarcinoma | Chromophobe Renal Cell Carcinoma | Papillary Renal Cell Carcinoma | Collecting Duct Carcinoma | Bladder... and other conditionsUnited States, Puerto Rico
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Renal Cell Carcinoma | Metastatic Lung Non-Small Cell Carcinoma | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Metastatic Melanoma | Fallopian Tube Carcinoma | Advanced Malignant Solid Neoplasm | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage III Renal... and other conditionsUnited States
-
Fundacion OncosurTerminatedRenal Cell Carcinoma Metastatic | Renal Cell Carcinoma Stage III | Renal Cell Carcinoma Stage IVSpain
-
Memorial Sloan Kettering Cancer CenterCompletedMetastatic Renal Cell Carcinoma | Fumarate Hydratase Deficient Renal Cell Carcinoma | Succinate Dehydrogenase Deficient Renal Cell CarcinomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Ovarian Carcinoma | Recurrent Head and Neck Carcinoma | Recurrent Renal Cell Carcinoma | Stage III Renal Cell Cancer | Endometrial Carcinoma | Stage III Bladder Cancer | Cervical Squamous Cell Carcinoma | Stage IV Breast Cancer | Malignant Uterine Neoplasm | Recurrent Bladder Carcinoma | Recurrent... and other conditionsUnited States
-
HiberCell, Inc.CovanceTerminatedA Study of HC-7366 to Establish the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D)Clear Cell Renal Cell Carcinoma | Non Small Cell Lung Cancer | Squamous Cell Carcinoma of Head and Neck | Colo-rectal Cancer | Transitional Cell Carcinoma of the Bladder | Other Solid TumorsUnited States
-
Five Prime Therapeutics, Inc.Bristol-Myers SquibbCompletedRenal Cell Carcinoma | Head and Neck Cancer | Pancreatic Cancer | Ovarian Cancer | Malignant Glioma | Advanced Solid Tumors | Non-small Cell Lung CancerUnited States
-
Lawson Health Research InstituteCompletedTransitional Cell Carcinoma | Renal Cell Cancer | Testicular CancerCanada